Novo Nordisk | Aktywa



Assets Zmiana Data
ANI Pharmaceuticals USD 1.29B 8.73M 2025-03
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 27.27B 845M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Merck USD 115.12B 1.98B 2025-03
Novartis USD 104.4B 4.45B 2025-06
Novo Nordisk 489.16B 91.72B 2025-03
Novo Nordisk DKK 489.16B 91.72B 2025-03
Pacira USD 1.59B 33.15M 2025-03
Perrigo USD 9.76B 112.1M 2025-03
Prestige Brands USD 3.4B 72.72M 2025-03
Sanofi 124.96B 6.93B 2025-06
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Zoetis USD 14.1B 139M 2025-03


Novo Nordisk Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.